← Browse by Condition
Medical Condition
biliary tract cancer
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 2, Phase 3
NCT03482102 Phase 2
Recruiting
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
Enrollment
70 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT06973161
Recruiting
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Enrollment
105 pts
Location
United States, Austr...
Sponsor
AstraZeneca
NCT06139042
Recruiting
Early-stage Detection of LIver, Biliary TRAct and PancReatic Cancers
Enrollment
1,608 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
NCT05520788
Recruiting
Ambispective Cohort Study of Precision Medicine for Primary Hepatobiliary Cancer Based on Next-generation Sequencing
Enrollment
200 pts
Location
China
Sponsor
Tongji Hospital
NCT06320301 Phase 2
Recruiting
Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)
Enrollment
43 pts
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital ...
NCT05065957 Phase 2, Phase 3
Recruiting
Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer
Enrollment
180 pts
Location
Taiwan
Sponsor
InnoPharmax Inc.